Benjamin H Han1, Joseph J Palamar2. 1. Department of Medicine, Division of Geriatric Medicine and Palliative Care, New York University School of Medicine, 550 First Avenue, BCD 615, New York, NY 10016 USA; Department of Population Health, New York University Langone Medical Center, 550 First Avenue, New York, NY 10016 USA; Center for Drug Use and HIV/HCV Research, New York University Rory Meyers College of Nursing, 433 First Avenue, 7th Floor, New York, NY 10010 USA. Electronic address: Benjamin.Han@nyumc.org. 2. Department of Population Health, New York University Langone Medical Center, 550 First Avenue, New York, NY 10016 USA; Center for Drug Use and HIV/HCV Research, New York University Rory Meyers College of Nursing, 433 First Avenue, 7th Floor, New York, NY 10010 USA.
Abstract
BACKGROUND: Marijuana use is increasing among middle-aged and older adults in the US, but little is understood of its pattern of use by this population. METHODS: We performed a cross-sectional analysis of responses from 17,608 adults aged ≥50 years from the 2015 and 2016 administrations of the National Survey on Drug Use and Health. Prevalence of past-year marijuana use was estimated and compared between middle-aged adults (age 50-64) and older adults (≥65). Characteristics of past-year marijuana users including demographics, substance use, chronic disease, and emergency room use, were compared to non-marijuana users and stratified by age group. Marijuana use characteristics were also compared between middle-aged and older adults. We used multivariable logistic regression to determine correlates of past-year marijuana use. RESULTS: Prevalence of past-year marijuana use was 9.0% among adults aged 50-64 and 2.9% among adults aged ≥65. Prevalence of past-year alcohol use disorder (AUD), nicotine dependence, cocaine use, and misuse of prescription medications (i.e., opioids, sedatives, tranquilizers) were higher among marijuana users compared to non-users. In adjusted models, initiation of marijuana use <19 years of age [adjusted odds ratio (AOR) = 13.43, 95% confidence interval (CI) 9.60, 18.78)], AUD (AOR = 2.11, 95% CI 1.51, 2.94), prescription opioid misuse (AOR 2.49, 95% CI 1.61, 3.85), nicotine dependence (AOR = 1.90, 95% CI 1.59, 2.26), and cocaine use (AOR 7.43, 95% CI 4.23, 13.03), were all associated with increased odds of past-year marijuana use. CONCLUSION: Marijuana use is becoming more prevalent in this population and users are also at high risk for other drug use.
BACKGROUND:Marijuana use is increasing among middle-aged and older adults in the US, but little is understood of its pattern of use by this population. METHODS: We performed a cross-sectional analysis of responses from 17,608 adults aged ≥50 years from the 2015 and 2016 administrations of the National Survey on Drug Use and Health. Prevalence of past-year marijuana use was estimated and compared between middle-aged adults (age 50-64) and older adults (≥65). Characteristics of past-year marijuana users including demographics, substance use, chronic disease, and emergency room use, were compared to non-marijuana users and stratified by age group. Marijuana use characteristics were also compared between middle-aged and older adults. We used multivariable logistic regression to determine correlates of past-year marijuana use. RESULTS: Prevalence of past-year marijuana use was 9.0% among adults aged 50-64 and 2.9% among adults aged ≥65. Prevalence of past-year alcohol use disorder (AUD), nicotine dependence, cocaine use, and misuse of prescription medications (i.e., opioids, sedatives, tranquilizers) were higher among marijuana users compared to non-users. In adjusted models, initiation of marijuana use <19 years of age [adjusted odds ratio (AOR) = 13.43, 95% confidence interval (CI) 9.60, 18.78)], AUD (AOR = 2.11, 95% CI 1.51, 2.94), prescription opioid misuse (AOR 2.49, 95% CI 1.61, 3.85), nicotine dependence (AOR = 1.90, 95% CI 1.59, 2.26), and cocaine use (AOR 7.43, 95% CI 4.23, 13.03), were all associated with increased odds of past-year marijuana use. CONCLUSION:Marijuana use is becoming more prevalent in this population and users are also at high risk for other drug use.
Authors: Benjamin H Han; Scott Sherman; Pia M Mauro; Silvia S Martins; James Rotenberg; Joseph J Palamar Journal: Addiction Date: 2016-12-05 Impact factor: 6.526
Authors: G B Chesher; H M Franks; V R Hensley; W J Hensley; D M Jackson; G A Starmer; R K Teo Journal: Med J Aust Date: 1976-07-31 Impact factor: 7.738
Authors: Matthew J Seamon; Jennifer A Fass; Maria Maniscalco-Feichtl; Nada A Abu-Shraie Journal: Am J Health Syst Pharm Date: 2007-05-15 Impact factor: 2.637
Authors: Rachel E Thayer; Sophie L YorkWilliams; Kent E Hutchison; Angela D Bryan Journal: Psychiatry Res Neuroimaging Date: 2019-02-10 Impact factor: 2.376
Authors: Navdep Kaur; Katherine M Keyes; Ava D Hamilton; Cath Chapman; Michael Livingston; Tim Slade; Wendy Swift Journal: Addiction Date: 2020-10-07 Impact factor: 6.526
Authors: Kevin H Yang; Christopher N Kaufmann; Reva Nafsu; Ella T Lifset; Khai Nguyen; Michelle Sexton; Benjamin H Han; Arum Kim; Alison A Moore Journal: J Am Geriatr Soc Date: 2020-10-07 Impact factor: 5.562
Authors: Jenny L Wiley; Daniel G Barrus; Charlotte E Farquhar; Timothy W Lefever; Thomas F Gamage Journal: Prog Neuropsychopharmacol Biol Psychiatry Date: 2020-08-15 Impact factor: 5.067